ArticleNPJ precision oncology2024

Targeting IGF-IR improves neoadjuvant chemotherapy efficacy in breast cancers with low IGFBP7 expression.

Christopher Godina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.